Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2021-03-15 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
前次募集资金使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "前次募集资金使用情况鉴证报告" which translates to "Previous Fundraising Usage Verification Report." It includes an auditor's verification opinion on the use of funds raised in a previous financing event, with detailed tables showing the use of funds, investment projects, and economic benefits realized. The document references compliance with China Securities Regulatory Commission rules on fundraising usage reports and includes an auditor's certification. This type of document is a standalone audit or verification report related to the use of previously raised capital, not a full annual or interim financial report. It is not an announcement or a brief summary but a detailed verification report. Therefore, it fits best under the category Audit Report / Information (AR). The document length (5020 characters) and content confirm it is a full report, not just an announcement or certification letter. Hence, the classification is AR with high confidence. FY 2020
2021-03-15 Chinese
独立董事2020年度述职报告（蔡辉益）
Board/Management Information Classification · 95% confidence The document is titled '独立董事2020 年度述职报告' which translates to 'Independent Director 2020 Annual Work Report'. It is a detailed report by an independent director about their duties, attendance, opinions on major company matters, committee work, investor protection efforts, training, and other work during the year 2020. The content focuses on governance, oversight, and compliance with laws and company rules. It does not contain financial statements or audit results, nor is it an announcement or certification. The document is a management-related report detailing board activities and governance oversight, fitting best under Board/Management Information (MANG). The document length is 3537 characters, which is sufficient for a substantive report rather than a brief announcement. Therefore, the classification is MANG with high confidence.
2021-03-15 Chinese
关于调整董事、监事、高级管理人员薪酬方案的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the adjustment of remuneration for the company's directors, supervisors, and senior management personnel. It details the salary principles, applicable personnel, and specific remuneration amounts. There is no financial data, audit information, or report content. It is not a full annual or interim report, nor a call transcript or earnings release. The document focuses on management compensation changes, which fits the definition of Remuneration Information (DEF 14A). The document length is short (1800 characters), and it is a direct announcement, not a report publication notice or certification. Therefore, the appropriate classification is DEF 14A.
2021-03-15 Chinese
关于修改公司章程的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the proposed amendment to the company's articles of association due to a change in registered capital following a share repurchase and cancellation of restricted stock. It includes details about the reduction in total shares and registered capital and the corresponding changes to the articles of association. The document is short (704 characters) and is an announcement of a corporate governance change related to capital structure, specifically the amendment of the company charter. It is not a full report, financial statement, or detailed management discussion. It is not a report publication announcement since it contains substantive content about the amendment. The document fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement about corporate governance and capital changes that does not fit more specific categories like Share Issue/Capital Change (SHA) because it is about amending the articles rather than issuing new shares. Therefore, the classification is Regulatory Filings (RNS).
2021-03-15 Chinese
关于召开2020年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2020 Annual General Meeting (AGM) of Tianjin Ruipu Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures, agenda items, and proxy forms. The document does not contain the actual annual report or financial statements but rather the notification and materials related to the AGM itself. The presence of agenda items such as approval of the 2020 annual report and financial statements indicates it is an AGM notice. The document length is 7273 characters, which is consistent with a detailed AGM notice rather than a full annual report. Therefore, the document fits the category of AGM Information (AGM-R).
2021-03-15 Chinese
关于终止向不特定对象发行可转换公司债券暨申请向特定对象发行股票事项的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Tianjin Ruipu Biotechnology Co., Ltd. regarding the termination of a previously planned convertible bond issuance to unspecified investors and the initiation of a new plan to issue shares to specific investors. It details board and supervisory committee meeting resolutions, independent director opinions, and references to prior shareholder meetings approving the original bond issuance plan. The document is an announcement of corporate financing decisions and changes in capital raising plans, not a full financial report or detailed financial data. It is relatively short (2339 characters) and serves as a notification of capital structure changes and financing updates. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2021-03-15 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.